Grande Prairie students launch campaign to support toddler with rare genetic disorder
The Grade 7 class at Ecole St. Gerard School has launched an awareness campaign in support of an Alberta toddler with a rare disorder.
Harper, a 14-month-old baby girl, is battling the rare disorder called Spinal Muscular Atrophy- Type 1 (SMA1). SMA is a genetic disorder caused by a lack of nerve cells, called survival motor neurons (SMN), which control muscle movement. This disorder tends to cause muscle weakness, breathing difficulties, along with trouble sucking and swallowing.
There is a treatment for SMA1, a one time IV treatment of Zolgensma, a drug by Novartis, which replaces the missing or non-working SMN gene with a working one. However, the drug has only been approved in the USA, Japan, and Europe.
In June 2020, Novaris applied to have the drug approved in Canada, but there are concerns it could take between 12 and 24 months to be approved at a federal level, and because Zolgensma is only prescribed to children under the age of two, time is of the essence.